Xiaodong Wang
王晓东
elsewhere's corpus does not cover this subject. No document chunk in the bundle is actually about Xiaodong Wang; the only retrieved material consists of background references where the name may appear incidentally alongside unrelated entities such as Yunqi Capital, Linear Capital, and BlueRun Ventures.
AI-generated — may contain errors, please verify.
Xiaodong WangPerson
王晓东
No graph yet
Mentioned in 3 articles
Coverage
"The China Nobel Prize" Marks Its Tenth Anniversary as Top Scientists Gather for a Future Appointment: Michael Mao of Yunqi Capital Attends the Future Science Forum
Going Deeper into Innovation
A Playbook for Billion-Dollar Drug Development: Navigating Uncharted Waters and Making Landfall | Ronghui
From Prozac to Gleevec — how to persevere on the long and winding road.
Vitaeon Therapeutics Completes $200 Million Series B Round to Develop Transformative Therapies for Aging-Related Degenerative Diseases
Transforming the treatment paradigm for age-related degenerative diseases, improving quality of life for millions of patients and families worldwide.
